Apr 12, 2017 8:00 am EDT Acasti Pharma to Present CaPre Omega-3 Bridging Study Results at National Lipid Association Scientific Sessions
Mar 8, 2017 8:00 am EST Acasti Pharma Forms Scientific Advisory Board and Appoints Two Leading Cardiovascular Disease Experts
Feb 2, 2017 11:31 am EST Acasti Pharma Announces Proposed Private Placement of Convertible Debentures and Amended Proposed Offering of Units
Oct 26, 2016 8:00 am EDT Acasti Pharma Builds Intellectual Property Portfolio with Newly Issued U.S. Patent for CaPre